Carol M. Julin
- Co-authors
- Kevin N. MorrisLarry GoldMichael R. WeilKirk B. JensenMark A. IsraelHiroko KuriyamaNagato KuriyamaKathleen R. Lamborn
- Topics
- RNA Interference and Gene Delivery (3 papers)Cancer-related Molecular Pathways (3 papers)Cell death mechanisms and regulation (2 papers)
- Journals
- Proceedings of the National Academy of SciencesAmerican Journal of Physiology-Cell PhysiologyAmerican Journal of Physiology-Renal Physiology
- Partner nations
- United StatesDenmark
In The Last Decade
Carol M. Julin
12 papers receiving 612 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 515
- Genetics 123
- Oncology 113
- Biomedical Engineering 100
- Cancer Research 53
Countries citing papers authored by Carol M. Julin
This map shows the geographic impact of Carol M. Julin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol M. Julin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol M. Julin more than expected).
Fields of papers citing papers by Carol M. Julin
This network shows the impact of papers produced by Carol M. Julin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol M. Julin. The network helps show where Carol M. Julin may publish in the future.
Co-authorship network of co-authors of Carol M. Julin
This figure shows the co-authorship network connecting the top 25 collaborators of Carol M. Julin. A scholar is included among the top collaborators of Carol M. Julin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol M. Julin. Carol M. Julin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model. | 50 |
| 3 | 13 | |
| 4 | 1 | |
| 5 | 70 | |
| 6 | Id gene expression as a key mediator of tumor cell biology. | 67 |
| 7 | 90 | |
| 8 | 259 | |
| 9 | 33 | |
| 10 | 4 | |
| 11 | 8 | |
| 12 | 7 | |
| 13 | 37 |
About Carol M. Julin
Carol M. Julin is a scholar working on Nephrology, Virology and Oncology, having authored 13 papers that have together received 639 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Cancer-related Molecular Pathways (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Molecular Biology (515 citations), Biotechnology (40 citations) and Genetics (123 citations). Carol M. Julin has collaborated with scholars based in United States and Denmark. Frequent co-authors include Kevin N. Morris, Larry Gold, Michael R. Weil, Kirk B. Jensen, Mark A. Israel, Hiroko Kuriyama, Nagato Kuriyama, Kathleen R. Lamborn, Michael Chobanian and Hui‐Kuo G. Shu. Their work appears in journals such as Proceedings of the National Academy of Sciences, American Journal of Physiology-Cell Physiology and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.